We also did not have the information in this study to determine when the pre-malignant lesions and tumors actually began to develop, thus, the variation of p16INK4a mRNA expression by breast carcinogenesis process cannot be accounted for in our analyses. The gene discussed is CDKN2A; the disease is neoplasm.